Rhythm Pharmaceuticals Inc (RYTM)
R&D Expense Growth
4.08%
Quarterly · Period ending:
RYTM R&D Expense Growth
Latest reported4.08%period ending
Latest reported4.08%period ending
RYTM Quarterly R&D Growth (QoQ) (0.00% → 4.08%)
Latest values, visible window
High-resolution chart · PNG
RYTM r&d expense growth history
Quarterly. Dates are reporting period ends; fiscal years can differ from calendar years.
| Period ending | R&D Expense Growth |
|---|---|
| 4.0815% | |
| -0.7328% | |
| -8.6755% | |
| 8.7879% | |
| 14.4294% | |
| -10.19% | |
| 8.5339% | |
| 26.3651% | |
| -76.6357% | |
| 329.7939% | |
| -10.9562% | |
| 0.0805% | |
| -11.601% | |
| 61.139% | |
| 11.5173% | |
| -32.8713% | |
| -3.2421% | |
| 2.9645% | |
| 14.6519% | |
| 9.6996% | |
| 26.0811% | |
| -9.3058% | |
| -4.5271% | |
| -0.0087% | |
| 2.1907% | |
| -9.2946% | |
| -6.631% | |
| -24.7423% | |
| 55.125% | |
| 21.3079% | |
| 75.2732% | |
| 24.7088% | |
| -30.1319% | |
| 84.6686% | |
| 11.4219% | |
| 10.6355% | |
| 10.7531% | |
| -13.4612% | |
| 3.9122% | |
| 19.5192% | |
| 13.0673% | |
| 10.8347% | |
| 64.6042% | |
| 230.03% | |
| 0% | |
| 7.5929% | |
| 914.7541% | |
| -97.4163% | |
| 0% | |
| 0% | |
| 0% |